A new systematic review looks at how artificial intelligence (AI) can be used with echocardiography, a type of ultrasound of the heart, to help people with hypertrophic cardiomyopathy (HCM). HCM is a condition where the heart muscle becomes abnormally thick, which can lead to serious problems. The review did not include any new patient data; instead, it examined existing research on AI methods in this area.
The review found that AI-based methods in echocardiography can be grouped by complexity, from simple single-frame analysis to more advanced approaches that model heart function over time and combine multiple views. These methods show potential for helping with diagnosis, telling HCM apart from other conditions, describing the disease's features, and predicting risk.
However, the review also points out important limitations. The AI tools are not always easy to interpret, meaning doctors may not understand why the AI makes a certain decision. Also, the data used in the studies are very different from one another, and there is not enough large-scale testing to confirm that these tools work well in real-world settings.
For now, this is early promise, not a ready-to-use tool. Patients with HCM should continue to follow their usual care and talk to their doctors about any new tests or treatments. The main takeaway is that AI-empowered echocardiography holds promise, but more research is needed before it can be widely used.
